RxDoctor Payments Data

Matthew Drakeley, MD

Pain Medicine · Coraopolis, PANPI 1962820373

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,714 of the $4,164 with a category attached, or 65.2%. Abbott accounts for 86.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $1,982 and has fallen 72.0% since, to $554 in 2025.

$4,164in general payments, 2019–2025

Across 87 payments — averaging $47.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Medtronic$174
  • Pacira Pharmaceuticals Incorporated$123
  • Curonix LLC$69
  • Averitas Pharma Inc.$54
  • Si-bone, Inc.$45
  • plus $89 from 4 others
$95,253in research payments, 2019–2025

Across 5 payments — averaging $19,051 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$95K

What the payments were for

  • Travel & lodging$1,45035%
  • Food & beverage$2,71465%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,164 in reported general payments places this provider in the 70th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$260,848
Medicare patients
419
Services billed
10,781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
QutenzaCapsaicin/Skin Cleanser13$46,186
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen524$10,236
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen371$8,708
Gabapentin190$2,432
Buprenorphine12$1,865
Morphine Sulfate ErMorphine Sulfate35$1,398
Celecoxib73$1,240
Pregabalin52$804
Tizanidine Hcl99$767
Cyclobenzaprine Hcl74$568
Baclofen75$565
Tramadol Hcl ErTramadol Hcl14$382
Diclofenac Sodium18$369
Tramadol Hcl53$306
Duloxetine Hcl16$172

Paid to pharmacies, not to this prescriber.

Other pain medicine in Coraopolis

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →